Tutorials › Pattern-Mixture and Selection Models › Auditing and Reporting an Identification Argument

Identifiability and Untestable Assumptions · Tutorial 78 of 499

Auditing and Reporting an Identification Argument

Build a transparent identification audit for a longitudinal trial estimand, and distinguish what the observed data establish from what assumptions supply.

Advanced 11 min read

What You'll Learn

  • Specify the observed-data law and the longitudinal trial target quantity.
  • Separate treatment randomization assumptions from assumptions about missing outcomes.
  • Derive a standardized mean contrast under conditional missing at random and positivity.
  • Identify which parts of an identification claim are testable and which are not.
  • Report sensitivity analysis and remaining sampling, modeling, and assumption uncertainty.

Why an Identification Audit Matters

A reported treatment effect can look precise while relying on assumptions that are easy to overlook. An identification audit makes the argument visible: it names the information actually observed, defines the target quantity, states the assumptions that connect the two, and describes what uncertainty remains. This is especially important in a longitudinal trial, where outcomes scheduled after baseline may be missing for some participants.

The audit is not a claim that assumptions have been proved by fitting a model. It is a structured account of the route from observed data to the estimand. The earlier material on observable implications and partial identification distinguishes restrictions that the data can assess from assumptions that concern unobserved outcomes. Here the goal is to report that distinction clearly for a trial estimand.

Definition: An identification audit is a transparent account of (1) the observed-data information, (2) the target estimand, (3) the assumptions under which the estimand is a function of the observed-data distribution, and (4) the uncertainty that remains after identification. Identification concerns whether the population target is determined; estimation concerns how it is estimated from a finite sample.

A Basic Longitudinal Trial Setup

Consider a trial with treatment assignment \(A\in\{0,1\}\), baseline covariates \(X\), and a final scheduled outcome \(Y\). Let \(R=1\) indicate that the final outcome is observed and \(R=0\) that it is missing. Baseline covariates and treatment assignment are recorded for everyone. The observed data for each participant can therefore be written as \((X,A,R,RY)\), where \(RY\) denotes the outcome when observed and carries no outcome value when \(R=0\).

Let \(Y^a\) be the final outcome that would be seen under assignment \(a\). One common target is the intention-to-treat mean difference in the trial population:

$$ \Delta = E[Y^1]-E[Y^0]. $$

This target compares outcomes under assignment, not necessarily outcomes under treatment received. To interpret it causally, the audit must state the relevant trial conditions. Random assignment makes \(A\) independent of the potential outcomes in the trial population; consistency connects the observed outcome under assigned treatment to the corresponding potential outcome; and no interference means one participant's assignment does not alter another participant's outcome. If these conditions fail, randomization alone does not justify the intended causal interpretation.

Missing outcomes create a separate identification issue. Randomization addresses the relation between assignment and potential outcomes; it does not, by itself, reveal the outcomes of participants with \(R=0\). For a simple identification argument, suppose the following conditions are invoked:

  • Conditional missing at random: \(Y\) and \(R\) are conditionally independent given \(A,X\), written \(Y\perp R\mid A,X\).
  • Response positivity: within covariate and treatment strata used for the target population, \(P(R=1\mid A=a,X=x)>0\).
  • Treatment positivity: each treatment assignment has positive probability in the target population. In a randomized trial this is supported by the randomization design.
  • Consistency and randomization: the assigned-arm observed outcomes represent the corresponding potential outcomes, subject to the trial conditions stated above.

Conditional missing at random is an identifying assumption, not a consequence of randomization. It says that among participants with the same treatment assignment and measured baseline covariates, the distribution of the final outcome is the same for responders and nonresponders. Since \(Y\) is unobserved when \(R=0\), this equality cannot be checked directly from the trial data.

From Observed Data to the Target

Under the assumptions above, the mean outcome in arm \(a\) can be obtained by first estimating the outcome mean among responders within each \(X\) stratum, then averaging those stratum means over the covariate distribution of the target trial population. The response indicator and covariates are observed, so the response probabilities and covariate distribution are part of the observed-data law. Conditional missing at random supplies the step that permits the responder outcome mean to stand in for the full stratum mean.

$$ E[Y^a] = \sum_x E[Y\mid A=a,X=x,R=1]P(X=x). $$

For continuous \(X\), the sum is replaced by an integral. In a randomized trial, the observed arm-specific conditional outcome distribution corresponds to the potential-outcome distribution under assignment \(a\), by randomization and consistency. Conditional missing at random then gives \(E[Y\mid A=a,X=x]=E[Y\mid A=a,X=x,R=1]\). Averaging over the target distribution of \(X\) yields the displayed expression. The contrast of the two arm-specific standardized means identifies \(\Delta\).

The positivity condition matters because a conditional responder mean cannot be learned from a stratum with no responders. Nor can the observed covariate strata represent the target population if some target strata are absent from the relevant treatment arm. A model may produce predictions in such empty regions, but those predictions depend on extrapolation rather than direct identification from observed support.

Worked Example: Auditing a Single-Stratum Mean Contrast

Suppose a hypothetical randomized trial assigns 100 participants to each arm. At the final visit, 80 of 100 assigned to treatment are observed, with mean outcome 10 points; 90 of 100 assigned to control are observed, with mean outcome 8 points. Assume the outcome is measured in points and there are no baseline covariates in this simplified illustration.

Observed-data information. The trial records assignment, final-visit response status, and the final outcome for responders. The response proportions are \(80/100=0.80\) in treatment and \(90/100=0.90\) in control. The observed responder means are 10 and 8 points.

Target quantity. The target is the trial-population mean outcome under treatment assignment minus the mean under control assignment.

Identifying assumptions. The randomized assignment, consistency, and no-interference conditions support the causal interpretation. The additional assumption \(Y\perp R\mid A\) says that within each arm the missing outcomes have the same mean as the observed outcomes. Both arms have responders, so response positivity holds in this one-stratum example.

Under that missingness assumption, the estimated arm means are 10 and 8 points, and the estimated contrast is

$$ \widehat{\Delta}=10-8=2.00\text{ points}. $$

The arithmetic is straightforward, but the audit must not describe the result as identified by randomization alone. Randomization identifies the treatment contrast only if the outcomes needed for the target are available or the missing-outcome assumption is added. The estimate also has sampling uncertainty; the calculation above is not a confidence interval.

Audit Covariate Adjustment Explicitly

With covariates, a pooled responder mean generally does not implement the standardization formula. The target population's covariate distribution should be stated, and the arm-specific responder means should be averaged over that distribution. This avoids silently changing the target to the covariate distribution among responders, which can differ between arms when response rates depend on \(X\).

Worked Example: Standardizing Over the Trial Population

Consider a hypothetical trial with two baseline strata. In the full randomized population, 60% have \(X=0\) and 40% have \(X=1\). Within \(X=0\), the treatment arm has a response rate of 0.90 and responder mean 12 points; the control arm has response rate 0.95 and responder mean 10 points. Within \(X=1\), the corresponding treatment values are 0.60 and 15 points, while the control values are 0.80 and 11 points.

For this audit, suppose randomization and consistency apply, conditional missing at random holds given \(A,X\), and response positivity holds in both strata and arms. Treatment positivity is supported by the trial design. These assumptions allow the observed responder means to represent the full stratum means; the response rates and stratum proportions are observed.

For treatment, standardize the two stratum means using the full trial proportions:

$$ \widehat{\mu}_1 =(0.60)(12)+(0.40)(15) =7.20+6.00 =13.20\text{ points}. $$

For control, the same target covariate distribution gives

$$ \widehat{\mu}_0 =(0.60)(10)+(0.40)(11) =6.00+4.40 =10.40\text{ points}. $$

Thus the standardized contrast is \(13.20-10.40=2.80\) points. Each calculation uses the same 60%/40% target composition, rather than the composition among responders. The assumptions do not become more credible merely because the strata are included; they must still be justified and their limitations reported.

Report What Is Assumed and What Remains Uncertain

A complete audit separates four kinds of statements. First, describe what is observed, including which variables are recorded for everyone and which outcomes are observed only for some participants. Second, define the estimand and its population, treatment contrast, outcome, and time point. Third, state each assumption that bridges the observed-data law to that estimand. Fourth, report what remains uncertain: finite-sample error, modeling choices, weak support or positivity, measurement error, and sensitivity to untestable assumptions.

The distinction between identification and estimation is essential. If a target is identified under stated assumptions, its population value is determined by the observed-data distribution under those assumptions. A sample estimate can still be imprecise, and a fitted model can still be misspecified. Conversely, a narrow standard error does not resolve uncertainty about whether the identifying assumptions are credible.

Observed-data diagnostics can reveal problems without validating the missingness assumption. Useful checks include tabulating response rates by arm and baseline covariates, examining whether important target strata have responders, and checking model fit for observed outcomes and response indicators. Sparse strata, extreme fitted response probabilities, or marked arm differences in response can signal instability or extrapolation. Good fit among observed records cannot establish how outcomes would have been distributed among nonresponders.

When the key assumption cannot be empirically verified, report how conclusions change under alternatives. A simple sensitivity parameter can describe the difference between the missing and observed outcome means within each arm. This does not identify the missing outcomes from the data; it makes the additional assumption explicit and shows its consequences.

Worked Example: Making Residual Missing-Outcome Uncertainty Visible

Return to a hypothetical trial with treatment responder mean 10 points and response proportion 0.80, and control responder mean 8 points and response proportion 0.90. Do not assume conditional missing at random. Instead, define \(\delta_a\) as the mean outcome among nonresponders in arm \(a\) minus the mean among responders in that arm. The values of \(\delta_a\) are not identified from these observed data.

The full arm mean is the response-weighted average of its responder and nonresponder means. Since the nonresponder mean is the responder mean plus \(\delta_a\), the treatment mean is \(10+(1-0.80)\delta_1\), and the control mean is \(8+(1-0.90)\delta_0\). Therefore,

$$ \Delta =2+0.20\delta_1-0.10\delta_0\text{ points}. $$

For an illustrative sensitivity scenario, suppose subject-matter judgment considers missing treatment outcomes 2 points lower than observed treatment outcomes and missing control outcomes 1 point lower than observed control outcomes. Then \(\delta_1=-2\) and \(\delta_0=-1\), giving

$$ \Delta =2+(0.20)(-2)-(0.10)(-1) =2-0.40+0.10 =1.70\text{ points}. $$

This is a scenario-based contrast, not a quantity learned solely from the observed outcomes. The audit should state who selected the sensitivity values, why they are plausible, and whether conclusions change across a prespecified range. Sampling uncertainty around estimates and uncertainty about the sensitivity values are distinct and should not be collapsed into one claim.

Common Audit Failures and Reporting Practice

A frequent mistake is to write, “The trial was randomized, so the treatment effect is identified,” even when final outcomes are missing. That reasoning confuses treatment assignment with outcome observation. Randomization supports comparability of treatment groups; it does not supply the unobserved outcomes. The correction is to state the missing-outcome assumption separately and show where it enters the identification argument.

A second mistake is to call a model-based result “identified” without naming its extrapolation assumptions. If some covariate-treatment strata contain no observed outcomes, a regression model may predict them, but the predictions depend on model form and cannot be checked against those absent outcomes. Report the support problem and distinguish model-based extrapolation from identification based on observed support.

For a concise report, give the audit in a fixed order:

1
Observed data.
List variables available for all participants, response indicators, and outcomes observed only when responses occur.
2
Target.
Define the trial population, treatment contrast, outcome scale, and scheduled time point.
3
Identification assumptions.
State randomization, consistency, no interference, missingness restrictions, and treatment and response positivity as applicable.
4
Identification argument.
Display the functional of the observed-data distribution that equals the target under those assumptions.
5
Residual uncertainty.
Separate sampling and estimation uncertainty from model dependence, limited support, and sensitivity to untestable assumptions.

The audit is useful even when the result is not point identified. It can show that the observed data restrict the target only to a range, or that a point estimate depends on a stated extrapolation. The appropriate conclusion is not that the analysis has failed, but that the strength of the claim should match the information and assumptions available. A transparent identification argument makes that match assessable.

Check Your Understanding

Answer each question, then compare your reasoning with the solutions below.

  1. In the trial setup, what information is observed for a participant with \(R=0\), and what part of the final outcome is unavailable?
  2. Why does randomization not, by itself, identify the final-visit mean contrast when outcomes are missing?
  3. In the standardization example, what is the treatment mean if the target population has 50% in each \(X\) stratum, with the same reported responder means?
  4. Using the sensitivity example, calculate the contrast when \(\delta_1=-1\) point and \(\delta_0=-2\) points.
  5. Name one diagnostic that can reveal a positivity concern and explain why it cannot verify conditional missing at random.

Solutions. (1) Assignment, baseline covariates, and response status are observed; the participant's final outcome is unavailable. (2) Randomization addresses assignment, not the distribution of outcomes hidden by nonresponse; an additional missing-outcome assumption or other identifying information is needed. (3) The treatment mean is \((0.50)(12)+(0.50)(15)=13.50\) points. (4) The contrast is \(2+(0.20)(-1)-(0.10)(-2)=2-0.20+0.20=2.00\) points. (5) Very low response rates or empty response strata within treatment-covariate groups indicate possible positivity failure. Such checks use observed response patterns; they cannot compare missing outcomes with outcomes that were observed, so they do not verify the conditional missing-at-random assumption.

Clinical Biostats